breast-cancer / English

add

FDA approves AstraZeneca and Daiichi's Enhertu combo for first-line HER2-positive breast cancer, while the EU clears Saphnelo self-injection for lupus.

A breast cancer diagnosis is hard enough – what happens when a mother and daughter go through it at the same time?

Tailoring breast cancer screening to a woman's individual cancer risk might work better than annual mammograms, researchers reported in a new study.

(MedPage Today) -- At the San Antonio Breast Cancer Symposium, researchers presented findings on Clarity BCR, a multimodal multitask deep-learning algorithm that aims to estimate late distant recurrence risk in hormone receptor (HR)…

"The brain is an exquisite sensor of what's going on in your body," says Cold Spring Harbor Laboratory Assistant Professor Jeremy Borniger. "But it requires balance. Neurons need to be active or inactive at the right times. If that rhythm…

(MedPage Today) -- The FDA approved trastuzumab deruxtecan (T-DXd; Enhertu) in combination with pertuzumab (Perjeta) for the first-line treatment of adults with unresectable or metastatic HER2-positive breast cancer.

(MedPage Today) -- At the San Antonio Breast Cancer Symposium, investigators from an international consortium reported that knowledge of BRCA1/2 mutation status strongly influenced surgical decision-making in young patients with stages I…

(MedPage Today) -- At the San Antonio Breast Cancer Symposium, researchers reported that real-time monitoring with smart pill bottles significantly improved adherence to adjuvant endocrine therapy compared with standard-of-care monitoring.

Greenwich LifeSciences Inc. (NASDAQ:GLSI) stock is trading higher on Monday, with a session volume of 2.804 million compared to the average volume of 81.85 thousand, as per data from Benzinga Pro.

Broadcast Retirement Network's Jeffrey Snyder discusses reducing the mortality of breast cancer with Steven Narod, MD, FRCPC, FRSC, Tier I Canada Research Chair in Breast Cancer, University of Toronto. Jeffrey Snyder, Broadcast Retirement…

They were reunited weeks after the TV presenter confirmed her own breast cancer diagnosis

(MedPage Today) -- SAN ANTONIO -- Preoperative radiotherapy (RT) plus PD-1 inhibitor pembrolizumab (Keytruda) significantly increased immune activation and tumor response in node-positive hormone receptor-positive (HR+)/HER2-negative…

Scientists have uncovered a powerful new antibody that disrupts a key protein helping triple-negative breast cancer survive and evade immunity. Triple-negative breast cancer (TNBC) is considered one of the most aggressive and difficult…

Davina McCall announced she had breast cancer in November, just one year after her brain tumour operation

The Strictly Come Dancing pro has opened up about life after being diagnosed with breast cancer

(MedPage Today) -- SAN ANTONIO -- Menopausal hormone therapy (MHT) did not increase breast cancer risk in women with BRCA mutations, according to a study reported here.

The Strictly Come Dancing star, 35, has undergone chemotherapy, fertility treatment and a mastectomy after being diagnosed with the disease in 2023.